- FDA News
-
by Skippack Pharmacy
GLP-1 Medication Shortage: Impact on Patients
The demand for GLP-1 receptor agonists has surged in recent years, primarily due to their effectiveness in managing type 2 diabetes and aiding weight loss. However, this increased demand has led to widespread shortages, leaving many patients struggling to access their prescribed medications.
The Growing Demand for GLP-1 Medications
According to the CDC, approximately 42% of American adults are classified as obese, and the need for effective weight management solutions continues to grow. GLP-1 receptor agonists have emerged as game-changers, helping individuals regulate blood sugar levels and achieve weight loss goals. However, the rising popularity of these medications for weight management—combined with an increase in off-label prescriptions—has led to supply constraints.
There is always the traditional diet and exercise program many are already working on but many patients want to expedite weight loss in addition to changing lifestyle.
Understanding GLP-1 Medications
GLP-1 receptor agonists are a class of medications that work by mimicking the natural GLP-1 hormone. This hormone helps regulate blood sugar levels, slow digestion, and suppress appetite, making these medications useful for diabetes management and weight loss.
Some common GLP-1 receptor agonists include:
- Semaglutide – Developed to manage type 2 diabetes and later found to aid weight loss.
- Tirzepatide – A dual GLP-1 and GIP receptor agonist that enhances insulin sensitivity and appetite regulation.
- Liraglutide – One of the first GLP-1 receptor agonists approved for weight loss.
Why is there a shortage?
The shortage of these medications is primarily due to increased prescriptions for weight loss. With rising media attention, social media trends, and celebrity endorsements, many people have turned to GLP-1 medications as a quick solution for shedding pounds. While these medications can be beneficial, their increased use has strained supply chains, making it difficult for individuals—especially those with type 2 diabetes—to obtain them.
What Happens When Supply Runs Low?
Pharmacies across the country report that a significant number of inquiries involve the availability of GLP-1 medications. Patients who rely on these medications for blood sugar control or weight loss may face difficulties in obtaining their prescribed doses, potentially disrupting their treatment plans.
One of the biggest concerns is that when patients stop taking these medications due to shortages, they may experience weight regain or worsened blood sugar control. This unpredictability can make long-term health management more challenging.
The GLP-1 medication shortage is an ongoing issue that affects thousands of patients nationwide. While these medications have proven benefits, accessibility remains a challenge. If you are struggling to find your prescription, consider speaking with your healthcare provider about potential alternatives. Additionally, maintaining a healthy lifestyle will always be a fundamental part of any weight management or diabetes care plan.
If you are experiencing difficulty accessing your prescribed medication, feel free to fill out our Type 2 Diabetes & Weight Loss Medication Shortage Inquiry Form to be notified when stock becomes available.
Click this LINK to inquire.
References:
https://www.cdc.gov/nchs/fastats/obesity-overweight.htm